Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Differentiation of Common Myeloid Progenitor Cells

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Correction: Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.

Bone marrow transplantation·2021

Same author

Hematopoietic cell transplant in pediatric acute myeloid leukemia after similar upfront therapy; a comparison of conditioning regimens.

Bone marrow transplantation·2021

Same author

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting.

Leukemia·2020

Same author

Correction: Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Leukemia·2019

Same author

T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol.

Leukemia·2019

Same author

Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia.

Leukemia·2018

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Current European practice in pediatric myeloablative conditioning.

K Vettenranta¹,

¹1Division of Hematology-Oncology and Stem Cell Transplantation, Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland. kim.vettenranta@hus.fl

Bone Marrow Transplantation

|July 24, 2008

Summary

Fractionated total body irradiation (fTBI) is a standard conditioning method for pediatric hematopoietic stem cell transplantation, despite long-term side effects. Alternative chemotherapy-only regimens are viable for specific pediatric indications, with ongoing research into novel conditioning strategies.

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Related Experiment Videos

Last Updated: Jul 4, 2026

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Busulfan as a Myelosuppressive Agent for Generating Stable High-level Bone Marrow Chimerism in Mice

Published on: April 1, 2015

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

Area of Science:

Pediatric Hematology
Oncology
Transplantation Medicine

Background:

Myeloablative conditioning is crucial for pediatric hematopoietic stem cell transplantation.
Fractionated total body irradiation (fTBI) is a common conditioning method for pediatric ALL, offering anti-leukemic effects but causing long-term sequelae.
Chemotherapy-only regimens are feasible and used for other pediatric indications like AML and severe aplastic anemia.

Purpose of the Study:

To review current conditioning strategies in pediatric hematopoietic stem cell transplantation.
To discuss the role of fractionated TBI and chemotherapy-only regimens.
To highlight emerging factors influencing conditioning regimen modification.

Main Methods:

Review of existing literature on conditioning regimens in pediatric transplantation.
Analysis of data on the efficacy and toxicity of different conditioning approaches.
Discussion of novel factors impacting conditioning strategies.

Main Results:

Fractionated TBI remains a cornerstone for pediatric ALL, despite known long-term effects.
Chemotherapy-only regimens are established for various pediatric hematologic malignancies and disorders.
Factors such as pre-transplant disease burden, HLA typing, and haploidentical transplantation are influencing current practices.

Conclusions:

Conditioning regimens in pediatric transplantation are evolving.
The choice of conditioning depends on the specific indication, disease status, and patient factors.
Further research is needed to optimize conditioning for improved outcomes and reduced toxicity.